We estimated the progression of brain atrophy and cerebrovascular lesions on MRI in a prospective cohort of patients with various manifestations of arterial disease. Within the SMART-MR study, using brain MRI data from baseline and after on average 3.9 years of follow-up, intracranial volume (ICV), total brain, cortical gray matter, ventricular, white matter lesion volumes and visually rated infarcts were obtained from 663 patients (mean age 57 ± 9 years, 81% men). Global and cortical atrophy increased quadratically with age. Men showed more progression of global and cortical atrophy than women (mean difference in change (95% CI): −0.25 (−0.44; −0.06) and −0.94 (−1.35; −0.52)% ICV) and had an increased risk of new brain infarcts (OR = 2.7, 95% CI 1.2-6.1). Compared with coronary artery disease patients, cerebrovascular disease patients showed more progression of cortical and subcortical atrophy and an increased risk of new brain infarcts, and peripheral arterial disease patients showed more progression of cortical atrophy. These results were independent of cerebrovascular lesions and cardiovascular risk factors. In patients with manifest arterial disease, brain atrophy tended to accelerate with older age and men had more progression of brain atrophy and cerebrovascular lesions than women. Additionally, patients with cerebrovascular and peripheral arterial disease showed the most prominent progression of atrophy and lesions.
Introduction
Cardiovascular disease is a major health problem worldwide, with coronary artery disease and stroke as the leading causes of morbidity and mortality. Improved possibilities to treat cardiovascular disease have led to increased survival rates of patients with cardiovascular disease. However, this has resulted in reduced health status and higher rates of functional disabilities in these aging patients [1] .
In patients with cardiovascular disease, cerebrovascular lesionssuch as brain infarcts and white matter lesions -and brain volume loss are common findings on magnetic resonance imaging (MRI) [2] . This is of clinical importance since it has been shown that the extent and rate of progression of these brain abnormalities increase the risk of cognitive and functional decline [3] [4] [5] .
Also, evidence has accumulated that cardiovascular risk factors and disease play an important role in the etiology of cerebrovascular lesions and brain atrophy [6] [7] [8] and it can therefore be suggested that persons with high vascular risk are more prone for accelerated brain aging. However, the effect of vascular disease present at various locations is not well studied.
In the general population, longitudinal studies have shown that loss of brain volume and accumulation of cerebrovascular lesions start at a slow rate in early adulthood and accelerate in older age [5, 6, [9] [10] [11] . However, to the best of our knowledge, no longitudinal studies have been performed in a population with vascular disease.
We estimated the rate of progression of brain atrophy and cerebrovascular lesions on MRI over on average 3.9 years of follow-up in a large cohort of patients with manifest arterial disease at various locations.
Details of the design and participants have been described elsewhere [2, 12] . In brief, between May 2001 and December 2005, all patients, from both hospitalized inpatients and outpatient clinics, newly referred to the University Medical Center Utrecht with manifest arterial disease, such as coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral arterial disease (PAD), and/or an abdominal aortic aneurysm (AAA), and without MR contraindications, were invited to participate. CAD was defined as myocardial infarction, coronary artery bypass graft surgery, or percutaneous transluminal coronary angioplasty in the past or at inclusion. Patients with a transient ischemic attack or stroke at inclusion and patients who reported stroke in the past were considered to have CVD. PAD was defined as surgery or angioplasty of the arteries supplying the lower extremities in the past or intermittent claudication or rest pain at inclusion. AAA was defined as present abdominal aortic aneurysm (aortic diameter ≥3 cm) or previous AAA surgery. Multiple vascular diseases were defined as having more than 1 vascular disease, possible in any combination. Information on surgical interventions related to the inclusion criteria was documented. During a 1-day visit to our medical center, all patients underwent an MRI of the brain, physical examination, ultrasonography of the carotid arteries, and blood sampling. Risk factors, medical history, and medication use were assessed with questionnaires. Between January 2006 and May 2009, follow-up measurements took place including MRI of the brain. In the period between baseline and follow-up measurements, patients received a questionnaire every six months to provide information on hospitalization and outpatient clinic visits. If a cardiovascular event or surgical intervention was reported, original source documents were retrieved and reviewed to determine the occurrence of cardiovascular disease and related surgical interventions. All possible events and surgical interventions were audited independently by three physicians.
The SMART-MR study was approved by the ethics committee of our institution and written informed consent was obtained from all participants [2] .
Magnetic resonance protocol and brain segmentation
At baseline and follow-up, the MR investigations were performed on a 1.5 T whole-body system (Gyroscan ACS-NT, Philips Medical Systems, Best, The Netherlands). The protocol consisted of transversal T1-weighted (repetition time [TR]/echo time [TE], 235/2 ms), T2-weighted (TR/TE, 2200/11 ms and 2200/100 ms), fast fluid-attenuated inversion recovery (FLAIR; TR/TE/inversion time [TI] , 6000/100/2000 ms), and inversion recovery (IR; TR/TE/TI, 2900/22/410 ms) sequences (field of view, 230 × 230 mm; matrix size, 180 × 256; slice thickness, 4.0 mm; no gap; 38 slices) [2] .
The T1-weighted gradient-echo, inversion recovery and FLAIR sequence were used for brain segmentation. The probabilistic segmentation technique has been described previously [13] . The segmentation program distinguishes cortical gray matter, white matter, sulcal and ventricular cerebrospinal fluid (CSF), and lesions. The results of the segmentation analysis were visually checked for the presence of infarcts and adapted if necessary to make a distinction between white matter lesions (WMLs) and infarct volumes.
Brain atrophy
At baseline and follow-up, total brain volume was calculated by summing the volumes of gray and white matter and, if present, the volumes of WML and infarcts. All volumes cranial to the foramen magnum were included. As a result, the total brain volume includes both the hemispheres, brainstem, and cerebellum. Total intracranial volume (ICV) was calculated by summing the total brain volume and the volumes of the sulcal and ventricular CSF. Total brain, cortical gray matter, and ventricular volumes were normalized for ICV and expressed as brain parenchymal fraction (BPF), cortical gray matter fraction (GMF), and ventricular fraction (VF) [2] . Change in BPF, GMF, and VF were used as indicators of progression of global, cortical, and subcortical brain atrophy.
White matter lesions and infarcts
At baseline and follow-up, the whole brain was visually searched for infarcts by a trained investigator and a neuroradiologist, blinded to the history and diagnosis of the patient. Discrepancies in rating were reevaluated in a consensus meeting. Infarcts were defined as focal hyperintensities on T2-weighted images of at least 3 mm in diameter. Infarcts located in the white matter also had to be hypointense on T1-weighted and FLAIR images in order to distinguish them from WML. Dilated perivascular spaces were distinguished from infarcts on the basis of their location, form, and the absence of gliosis [14] . The location, affected flow territory and type were scored for every infarct. Brain infarcts were categorized as cortical infarcts, large subcortical infarcts, lacunar infarcts, and infratentorial infarcts. We defined large subcortical infarcts as infarcts sized N15 mm and not confluent with cortical infarcts. Lacunar infarcts were defined as infarcts sized 3-15 mm in diameter and located in the subcortical white matter, thalamus, or basal ganglia. Infratentorial infarcts were located in the brainstem or cerebellum. Volumes of periventricular and deep WML were summed to obtain the total volume of WML. Periventricular lesions were defined as WML adjacent to or within 1 cm of the lateral ventricles in both hemispheres and deep lesions were located in the deep white matter tracts and may or may not have adjoined periventricular lesions [2] . WML volumes were natural log transformed at baseline and follow-up, because they were not normally distributed.
Vascular screening
During the patient's visit to the medical center, an overnight fasting blood sample was taken to determine glucose and lipid levels. Height and weight were measured without shoes and heavy clothing, and the body mass index (BMI) was calculated (kg/m 2 ). Systolic and diastolic blood pressures (mmHg) were measured twice with a sphygmomanometer and the average of the two measures was calculated. Diabetes mellitus at baseline was defined as a referral diagnosis of diabetes mellitus, self-reported diabetes mellitus (use of glucose-lowering agents), glucose ≥11.1 mmol/L, or a known history of diabetes mellitus. Among subjects without a history of diabetes mellitus, but with a fasting plasma glucose ≥ 7.0 mmol/L at baseline, those receiving treatment with glucose-lowering agents within 1 year after baseline were considered as having diabetes mellitus at baseline. Hyperlipidemia was defined as total cholesterol N5.0 mmol/L, low-density lipoprotein cholesterol N 3.2 mmol/L, or self-reported use of lipid-lowering drugs. Smoking habits and alcohol intake were assessed with questionnaires. Pack years of smoking were calculated and alcohol intake was categorized as never, former, or current. Patients who had quit drinking during the past year were assigned to the category current alcohol use. Ultrasonography was performed to measure the intima-media thickness (IMT) (mm) in the left and right common carotid arteries, represented by the mean value of six measurements [7] .
Study sample
At baseline, 1309 patients participated in the baseline examination. The median interval between index cardiovascular event and MRI scan was 3.3 months (10th-90th percentile: 1.4-9.8 months). For patients who were recruited after an acute stroke (n = 40), median interval between event and participation was 3.6 months, with a 10th-90th percentile of 1.1 and 10.1 months. Of these 1309 patients, 19 had no MRI, and 14 had no FLAIR sequence. In addition, in 44 patients brain volume data were missing due to motion or artifacts. As a result, baseline MRI data were available in 1232 patients.
At follow-up, all patients were invited in the same order as they were included at baseline, so that every patient had a follow-up examination after a median (interquartile range) follow-up period of 3.8 (3.7-4.1) years. Due to logistics and MRI capacity, it was not possible to have an exact follow-up period of 4 years for every patient. Of 1232 patients, 718 patients participated in the follow-up examination. Of these, 38 had no MRI, and in 17 patients brain volume data were missing due to motion or artifacts. Due to a temporary change in the MRI protocol, the IR sequence was missing in 116 patients and not adequate in 20 patients. This resulted in missing data on cortical gray matter in these 136 patients, as the IR sequence was obligatory for cortical gray matter segmentation. For segmentation of the other brain volumes, it was possible to only use the FLAIR sequence [7, 13] . As a result, the analyses on the prospective data were performed in 663 patients.
Our sample (n = 663) was younger, more often male, had more CAD and less PAD and multiple vascular diseases, had lower blood pressure levels, less often diabetes mellitus, and had less cerebrovascular lesions on MRI than the 569 patients who did not participate in the follow-up examination.
Data analyses
We used multiple imputation (10 datasets) using the statistical program R (aregImpute; version 2.10.0) to address missing values in the study sample of 663 patients. Data were analyzed using SPSS version 20.0 (Chicago, IL, USA), by pooling the 10 imputed datasets [15] .
First, baseline characteristics were calculated for the total study population and according to 3 age groups (b55 years, 55-64 years, and ≥65 years) and sex. Second, linear regression analysis was used to estimate the association of age (continuous and in 3 groups) and sex with change in BPF, GMF, VF, and WML volume. Logistic regression analysis was used to estimate the association of age and sex with any new brain infarct (all, cortical, and lacunar). New brain infarcts were calculated by subtracting the number of infarcts at baseline from the number of infarcts at follow-up. This number of infarcts was dichotomized for analysis as no new infarcts (≤ 0) and ≥ 1 new infarcts at follow-up. The respective brain MRI measures at follow-up were entered as dependent variable and age, sex, duration of follow-up period, and baseline brain MRI measures were entered as independent variables (model 1). When progression of brain atrophy was the outcome, additional adjustments were made for baseline brain infarcts and WML volume; when progression of WML was the outcome, additional adjustments were made for baseline brain infarcts and BPF; when new brain infarcts were the outcome, additional adjustments were made for baseline WML and BPF (model 2). Furthermore, in model 3 additional adjustments were made for cardiovascular risk factors (BMI, smoking, alcohol use, systolic and diastolic blood pressure, hyperlipidemia, diabetes mellitus, intima-media thickness).
To assess whether progression of brain atrophy or cerebrovascular lesions accelerated with age, quadratic age-terms were entered to model 1. To investigate whether the rate of progression of brain MRI outcomes associated with age differed for men and women, analyses were repeated across strata of sex and interaction terms between age and sex were added to the regression models (model 1).
Finally, to investigate the association of vascular disease categories (CAD, CVD, PAD, AAA, or multiple vascular diseases) with progression of brain atrophy or cerebrovascular lesions, these categories were added to model 1. Patients with CAD were used as the reference category.
Results
The mean (SD, range) age of the population was 57 (9, 28-79) years and 81% were men. Table 1 shows baseline characteristics across 3 age groups and for men and women, see Supplemental Table 1 .
After a median (interquartile range) follow-up period of 3.8 (3.7-4.1) years, the mean (SD) decrease in BPF and GMF was 0.98 (1.08)% ICV and 1.72 (2.17)% ICV, and the mean (SD) increase in VF was 0.19 (0.28)% ICV (Supplemental Table 2 ). The mean WML volume increase was 0.06% ICV, ranging from 0.01% ICV in the youngest age group to 0.13% ICV in the oldest age group, and 82 patients (12% of 663) had one or more new brain infarcts; 3% was due to new cortical infarcts, 9% to new lacunar infarcts, and 1% to new infratentorial infarcts. One new large subcortical infarct was observed (Supplemental Table 2 ). Forty-four percent of the new brain infarcts were silent.
Age and sex
Older age was associated with more progression of brain atrophy and cerebrovascular lesions during follow-up ( Table 2 ). The mean differences in change (95% CI) in BPF, GMF, and VF between older (≥ 65 years) and younger patients (b 55 years) were − 1.20 (−1.43; − 0.97)% ICV, −1.58 (−2.07; −1.10)% ICV, and 0.19 (0.14; 0.25)% ICV. In younger patients, change in natural log transformed WML volume was negative: mean difference in change (95% CI) was −0.16 (−0.25; −0.08)% ICV. However, with increasing age, natural log transformed WML volume increased, irrespective of other baseline brain MRI measures and cardiovascular risk factors ( Table 2 , models 2 and 3).
Older patients also showed a fourfold increased risk of new brain infarcts (Table 2 , model 1), but this could partly be explained by WML volume, total brain volume, and cardiovascular risk factors (models 2 and 3). Furthermore, age-squared was associated with decreases in BPF (p = 0.08) and GMF (p = 0.03) over time, indicating that the atrophy tended to accelerate with older age. Compared with women, men showed a larger age-adjusted decrease in BPF and GMF over time: mean differences in change (95% CI) between men and women were − 0. (Table 2 and  Supplemental Table 3 ). Similar risk estimates were shown in model 2 and 3 (model 2: OR = 3.03, 95% CI 1.28-7.14 and OR = 3.60, 95% CI 1.20-10.80, respectively and model 3: OR = 3.24, 95% CI 1.33-7.92 and OR = 3.29, 95% CI 1.84-5.86, respectively). No differences between men and women were observed with respect to change in VF or WML volume over time (Table 2) .
A significant interaction between age and sex was present for change in GMF (p = 0.02). Stratified analyses showed that with older age, men had a larger decrease in GMF than women (Fig. 1b) . This interaction was not observed for BPF, VF, or WML (Fig. 1a, c, d ).
Vascular disease
Compared with patients with CAD, patients with CVD showed larger decrease in GMF and larger increase in VF during follow-up after adjusting for age and sex; mean differences in change (95% CI) were − 0.67 (− 1.13; − 0.20)% ICV and 0.11 (0.05; 0.16)% ICV (Table 2 , model 1). The relation between CVD and VF showed similar effect estimates in models 2 and 3 (model 3: 0.09 (0.03; 0.15)% ICV), but the effect estimates for the relation between CVD and GMF diminished and were no longer significant after further adjustments (model 3: −0.18 (−0.70; 0.33)% ICV). CVD patients showed more new brain infarcts and in particular new cortical infarcts (Table 2 and Supplemental Table 3 ). In models 2 and 3, these risk estimates only marginally changed.
Patients with PAD showed a larger age and sex-adjusted decrease in GMF over time than patients with CAD (mean difference in change (95% CI): −0.63 (−1.15; −0.12)% ICV (Table 2, model 1)), and this was irrespective of baseline cerebrovascular lesions and cardiovascular risk factors (model 3: −0.63 (−1.16; −0.10)% ICV).
Furthermore, AAA patients showed a significantly larger increase in VF than patients with CAD after adjusting for age and sex; mean difference in change (95% CI) was 0.13 (0.02; 0.24)% ICV (Table 2, model 1). However, this was partly explained by cardiovascular risk factors (model 3). Patients with AAA also showed more new brain infarcts and in particular new cortical infarcts in model 1 ( Table 2 and Supplemental Table 3 ). However, these findings were partly explained by WML volume, total brain volume, and cardiovascular risk factors (model 3: OR = 3.05, 95% CI 0.94-9.90 and OR = 6.98, 95% CI 1.03-47.52).
Patients with multiple vascular diseases showed no difference in change in brain volumes or progression of any infarct when compared with CAD patients.
Additional analyses were performed to study whether the accrual of new brain infarcts or WML volume change altered the associations, whether new vascular events during follow-up were of influence, and whether treatment effect was an issue in this study. First, progression of brain infarcts and WML volume was added to model 1. Results showed that the observed associations somewhat attenuated, but remained statistically significant (Supplementary Table 4, model 4) .
Second, new vascular events during follow-up were added to model 3. Results showed no significant change in the effect estimates of the found associations (Supplementary Table 4, model 5) . Third, to study a possible treatment effect, analyses were repeated in a subset of the study population who had not undergone a surgical intervention prior to inclusion in the study (n = 170, 26%) and the effect estimates of the associations of age and sex with changes in brain volumes and risk of new brain infarcts were similar (Supplementary Table 5 ). However, due to loss of power, we were not able to study a possible treatment effect on the associations of vascular disease categories with brain changes in this subset. Also, we additionally adjusted the analyses for surgical interventions during follow-up for the total study population (n = 663) (Supplementary Table 4 , model 6) and the effect estimates shown in Table 2 did not materially change.
Finally, since post-stroke focal brain atrophy can contribute to the progression of brain atrophy in this population, we performed sensitivity analyses excluding 15 patients who were recruited within 90 days after an acute stroke, and the results did not materially change.
Discussion
Within a large cohort of patients with various manifestations of arterial disease, we observed progression of global, cortical, and subcortical brain atrophy over 3.9 years of follow-up. With older age, progression of global and cortical atrophy tended to accelerate and was stronger in men than in women. Our results are in line with population-based longitudinal studies reporting annual gross brain volume decreases in the order of 0.2-0.6%, depending on the age of the cohort [9] [10] [11] 16] . Compared with our cross-sectional findings [2] , changes in BPF and GMF are larger in our longitudinal analyses. This finding is in contrast with results in some earlier studies [9, 10, 17] , but confirmed in at least one other study [11] . Although there is no evident explanation for the difference in our cross-sectional and longitudinal findings, issues related to survival, non-response, or cohort effects might all have contributed to this difference.
Our finding that with older age, men showed more progression of cortical atrophy than women is in line with our cross-sectional findings [2] and other studies [11, 18, 19] , although not all [17, 20, 21] . This finding may be explained by the finding that compared with women, men more often had an unfavorable cardiovascular risk profile in our study population. However, adjusting for these cardiovascular risk factors did not explain the difference in progression of brain atrophy. In addition, it has also been suggested that sex hormones or differences in regional brain metabolism between men and women might play a role in brain atrophy, but the exact mechanisms are not entirely clear [19] .
In younger patients, we observed regression of WML volume, which was somewhat surprising. An explanation for the negative change in WML volume could be that WMLs are no longer measurable due to brain atrophy of the surrounding tissue or due to a nearby infarct. Other explanations are measurement error, since the WML volumes at baseline were already quite small, or resolution of WMLs. Earlier studies have suggested that WMLs are not irreversible [22, 23] . In addition, we observed progression of WML volume with age, which was similar for men and women. Other longitudinal studies who used volumetric assessment of change in WML volume reported similar [11] or somewhat larger changes in WML volume [24, 25] . However, these studies were performed in smaller and older samples of the general population and the results may therefore be not fully comparable.
The risk of new brain infarcts also increased with age and was stronger in men than in women, particularly for new lacunar infarcts. This finding is in contrast with our cross-sectional findings and the results from a population-based longitudinal study on new brain infarcts, where there were no significant sex differences [2, 26] . Additionally, for lacunar infarcts, a cross-sectional study in the general population showed a higher risk for women instead of men [27] , while another population-based study did not [28] . These inconsistent findings make it difficult to explain the association of new brain infarcts with male sex.
With respect to the different vascular disease locations, we found that, compared with CAD patients, patients with CVD had more progression of cortical and subcortical atrophy, and more new brain infarcts, in particular new cortical brain infarcts. However, the association with progression of cortical atrophy was partly explained by the presence of cerebrovascular lesions, such as brain infarcts and WMLs.
PAD patients had more progression of cortical atrophy compared with patients with CAD. These findings were independent of the presence of cardiovascular risk factors at baseline. Although we know that when manifest arterial disease is present in one vascular bed, there is an increased risk for developing manifest arterial disease in other vascular beds [29] , our findings suggest that manifest arterial disease at different locations might differentially influence progression of brain atrophy and cerebrovascular lesions. Earlier studies relating arterial disease to progression of brain pathology only evaluated patients with vascular disease present in one vascular bed. Presence of carotid atherosclerosis has been associated with increased risk of new brain infarcts, WMLs, and progression of brain atrophy [7, 23, 30] . Although there is little evidence on the relation between peripheral and abdominal atherosclerosis and progression of brain pathology, one cross-sectional study showed that aortic atherosclerosis was associated with more WMLs [31] . The possible differential effect of the location of arterial disease on progression of brain atrophy and/or cerebrovascular lesions could be explained by differences in cardiovascular risk factors or differences in treatment strategies between the vascular disease categories. We could only partly account for these possible differences by adjusting for baseline risk factors, but additional analyses suggested that our results could not be explained by treatment effects prior or during follow-up. Also, differences in hemodynamics, remodeling properties, and/or underlying arterial wall structure of the different vascular beds could play a role in the differential effect of the location of arterial disease on progression of brain atrophy and/or cerebrovascular lesions [32] .
To our knowledge, our study is the first to prospectively examine brain changes on MRI in a large cohort of well-defined patients with various manifestations of arterial disease. Other unique aspects of this study are the wide age range of the population and the availability of brain volumetric measurements on MRI at baseline and follow-up. This made it possible to differentiate between the different brain tissues and to obtain relatively precise estimates of progression of brain atrophy and cerebrovascular lesions.
Limitations of this study are, first, that individuals who participated in the follow-up examination represented a relatively healthy group. This may have led to an underestimation of the progression of brain atrophy and cerebrovascular lesions. Second, the number of new brain infarcts was relatively small, especially new cortical and lacunar infarcts.
This resulted in reduced power and the associations found in this study should therefore be interpreted with caution. Third, patients were classified in five distinct vascular disease categories according to patient history and inclusion criteria at baseline. Vascular events that took place in the follow-up period were, however, not included in the category definition. However, we did perform additional analyses adjusting for vascular events during follow-up and the results did not change.
In conclusion, in a large cohort of patients with various manifestations of arterial disease, we observed trends in accelerated progression of brain atrophy and progression of cerebrovascular lesions, especially in older men and patients with CVD or PAD.
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